HBA’s Building Better Business Connections (3BC) program brings executive leaders together to form a community with the common purpose of accelerating the business value of women leaders in the healthcare and life sciences industry. Each summit is highly interactive and brings diverse industry voices together to create engaging and effective dialogue. This program is offered exclusively to HBA Corporate Partner organizations and is one of the top-rated package offerings.
3BC holds at least one executive summit per year. Summits are focused on individual and organizational transformation opportunities which help companies realize the full potential of the female talent pipeline and advance the impact and influence of that pipeline across the industry.
The topic/focus for the summit varies year to year based on current industry issues and is determined by the 3BC event chair(s) and HBA senior staff. Sessions are facilitated by an industry leader, a recognized though leader and/or a professional subject matter expert. The content brings forth best practices and practical innovations more so than academics and theory.
Program Content
2018 - Optimizing the Role of Male Champions (program), sponsored by Johnson & Johnson
2017 - Technology and Gamification: Turning Disruption into Opportunity for Women & Business (program agenda and speakers), sponsored by KPMG
2016 - Women Leaders Transforming the Future Through Gender Partnership
2015 - Building and Growing Internal Women’s Networks (IWN)
2015 - Metrics that Matter: Strategies to Build the IWN Business Case for Change
2014 - Blind Spot: Hidden Biases of Good People
2013 - Creating a Sponsorship Culture
2012 - Innovation: Diversity and Market Growth
2011 - The Power of the Purse
Leadership
3BC is chaired by two senior leaders from HBA’s Corporate Partners. These are highly visible HBA leadership roles, providing significant visibility across the industry and opportunities for strategic networking.
Find out more about the current 3BC co-chairs.
Participant Profile
- 30 or more unique healthcare and life sciences companies are represented
- 70 percent of attendees are director level and above
- 30-40 percent of attendees are vice president level or higher